Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.21622 | 8 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.20059 | 8 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.19257 | 8 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.17071 | 9 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.1587 | 8 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.33433 | 11 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.28566 | 11 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.30152 | 13 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.17688 | 8 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.19389 | 8 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.19413 | 9 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.22194 | 10 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.20797 | 9 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.18911 | 8 |